Proton Pump Inhibitor (PPI)
Pregnancy: Generally considered safe. Omeprazole most studied in pregnancy.
Omeprazole / Lansoprazole (LPR)
Brand names: Losec (omeprazole), Zoton (lansoprazole)
Adult dose
Dose: Omeprazole 20–40 mg twice daily or Lansoprazole 30 mg twice daily for 8–16 weeks (LPR)
Route: Oral (before meals, 30–60 minutes before eating)
Frequency: Twice daily (LPR requires higher frequency than GORD)
Max: 40 mg twice daily (omeprazole); 60 mg/day (standard GORD use)
Laryngopharyngeal Reflux (LPR): 2× daily PPI for 16 weeks minimum. Standard GORD: 20 mg OD. H. pylori eradication triple therapy: 20 mg BD + clarithromycin 500 mg BD + amoxicillin 1 g BD for 7 days.
Paediatric dose
Dose: 0.7 mg/kg
Route: Oral
Frequency: Once daily
Max: 20 mg/day (children <10 kg); 40 mg/day (≥20 kg)
1–11 years: 0.7–1.4 mg/kg OD (max 20 mg OD for <10 kg, up to 20 mg OD for 10–20 kg). ≥12 years: adult dose. Omeprazole dispersible tablets available for younger children.
Dose adjustments
Renal
No dose adjustment required.
Hepatic
Max 20 mg/day in severe hepatic impairment.
Paediatric weight-based calculator
1–11 years: 0.7–1.4 mg/kg OD (max 20 mg OD for <10 kg, up to 20 mg OD for 10–20 kg). ≥12 years: adult dose. Omeprazole dispersible tablets available for younger children.
Clinical pearls
- LPR requires TWICE DAILY dosing (unlike GORD where once daily usually sufficient)
- Twice-daily dosing: take 30–60 min before breakfast and 30–60 min before evening meal
- H. pylori eradication: use clarithromycin-based triple therapy (7 days) or bismuth quadruple therapy
- Step-down after H. pylori eradication — confirm eradication with urea breath test 4 weeks after stopping
- Review long-term PPI use annually — deprescribe if no longer indicated
Contraindications
- Hypersensitivity to PPIs
- Concomitant use with rilpivirine, atazanavir, nelfinavir
Side effects
- Headache and GI upset
- Hypomagnesaemia (prolonged use)
- Osteoporosis and fractures (prolonged use)
- Clostridium difficile (increased risk with prolonged use)
- Hyponatraemia
- Subacute cutaneous lupus erythematosus (rare)
Interactions
- Clopidogrel — omeprazole reduces antiplatelet effect (use lansoprazole/pantoprazole instead)
- Methotrexate — high-dose PPIs may increase MTX levels
- Warfarin — increased INR in some patients
- Rilpivirine, atazanavir — contraindicated (reduced absorption)
Monitoring
- Symptom response
- Serum magnesium (prolonged use)
- Bone density (long-term use)
- H. pylori eradication if indicated
Reference: BNFc; BNF; NICE CG184; British Society of Gastroenterology H. pylori guidelines. Verify against your local formulary and the latest BNF before prescribing.
Related
Curated clinical cross-links plus same-class fallbacks.
Calculators
- SMART Risk Score for Recurrent CVD · Cardiovascular Risk
- IABP Timing Assessment · Mechanical Circulatory Support
- PCSK9 Inhibitor Eligibility Assessment · Lipid Management
- Immune-Related Adverse Events (irAE) -- GI Toxicity Colitis Grading · Oncology-Related GI
- irAE Hepatitis Grading (CTCAE) · Immunotherapy
- DIPSS — Dynamic International Prognostic Scoring System for Myelofibrosis · Cancer Prognosis
Drugs
Pathways
- Adult Upper Airway Obstruction (Stridor) · DAS 2015 unanticipated difficult airway; RCEM
- Epistaxis Management · ENT-UK / NICE
- Acute Otitis Media · NICE NG91 2018
- Tonsillitis and Sore Throat · NICE NG84 2018
- Benign Paroxysmal Positional Vertigo · NICE CG124 / AAO-HNS Guidelines
- Acute Rhinosinusitis · NICE NG79 2017 / EPOS 2020